Neurosense Therapeutics Ltd
NRSN
詳細チャートを表示
0.940USD
+0.070+8.03%
終値 02/06, 16:00（ET）15分遅れの株価
23.12M時価総額
損失額直近12ヶ月PER
Intraday
1m
30m
1h
D
W
M
D
本日
+8.03%
5日間
+2.16%
1ヶ月
+7.91%
6ヶ月
-29.86%
年初来
+22.22%
1年間
-20.48%
詳細チャートを表示
TradingKey 株式スコア
データが不十分なため、株式スコアは利用できません。
Neurosense Therapeutics Ltd ニュース
最新情報をお待ちください...
財務指標
EPS
会社から関連データがまだ開示されていません。
総売上高
会社から関連データがまだ開示されていません。
Neurosense Therapeutics Ltdの企業情報
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
企業コードNRSN
企業名Neurosense Therapeutics Ltd
最高経営責任者「CEO」Ben-Noon (Alon)
ウェブサイトhttps://www.neurosense-tx.com/
関連金融商品
+3.66%
+3.14%
+0.93%
+2.01%
+1.82%
+1.60%
-0.95%
+4.49%
+2.10%
+9.92%
+2.76%
+4.15%
+1.79%
+4.17%
+0.72%
+1.10%
+2.46%
0.00%
+0.51%
+0.54%人気銘柄
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
70051.730
+81.600 (+0.12%)
282.580
+22.390 (+8.61%)
2079.770
+28.040 (+1.37%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
